alfentanil has been researched along with Carcinoma, Hepatocellular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Curley, SA; Dougherty, TB; Mikolajek, JA | 1 |
1 trial(s) available for alfentanil and Carcinoma, Hepatocellular
| Article | Year |
|---|---|
Safe anesthetic management of patients undergoing a novel method of treating human hepatocellular cancer.
Topics: Adrenergic alpha-Agonists; Adult; Aged; Alfentanil; Anesthesia, Intravenous; Anesthetics, Intravenous; Antibiotics, Antineoplastic; Carcinoma, Hepatocellular; Doxorubicin; Extracorporeal Circulation; Filtration; Hemodynamics; Hepatic Artery; Humans; Infusions, Intra-Arterial; Middle Aged; Monitoring, Physiologic; Phenylephrine; Propofol | 1997 |